US-based digital health company, Oshi Health has released a new mHealth app to help people with Inflammatory Bowel Disease (IBD) with symptom tracking, curated learning and expert Q&A.

The app, which is simply called Oshi, is available for free for both Apple and Android devices from their respective stores.

IBD is marked by chronic inflammation in the lining of the gastrointestinal tract. Currently, there is no known cause or cure for Crohn’s disease or ulcerative colitis, the two main forms of IBD.

While the frequency, duration and severity of symptoms is variable and not clearly understood, research shows that the interaction between genes, the body’s immune system, and environmental factors may play a role. Also many factors, including lifestyle behaviours like sleep, diet and exercise can greatly impact IBD wellness.

Keeping track of these many daily factors — and IBD symptoms — is an important part of helping individuals better understand the causes of flare-ups and how best to achieve ongoing well-being.

According to Oshi Health, their platform was designed to meet these needs and empower IBD patients with managing their disease by providing tools to track, learn and ask.

“Oshi is a free mobile app that empowers individual control and understanding of IBD wellness. Oshi has the potential to significantly improve lives with smart tools to manage and control Crohn’s disease and ulcerative colitis,” said Oshi Health CEO, Daniel Weinstein.

“Oshi’s easy-to-use, best-in-class tracking and insights tool will allow patients to work with their physicians to uncover hidden patterns to figure out what triggers flares for their unique bodies,” continued Weinstein.

In addition to tracking and scoring, Oshi incorporates articles to inform, assist and uplift patients. Exclusive content includes real-life success stories, easy-to-understand info on emerging treatments and IBD-friendly recipes.

“Curated content is core to Oshi. We work closely with Patient Advocates and Physician Partners to provide important information on IBD. Oshi Health will continue to add new articles and features based on recommendations from our community,” said Head of Product at Oshi Health, Barak Poker.

“Just like tracking, we know that each individual is unique when learning. Oshi provides personalised content recommendations to match users’ interests,” continued Poker.

Oshi also offers an “Ask the Experts” feature to further support the tracking and learning digital experience. Through this feature a team of gastroenterologists and health professionals provide moderated feedback on key questions.

“Oshi Health’s platform is a tremendous opportunity to advance the care of IBD patients by facilitating provider/patient conversations. Physicians like me can now access key information and view dashboards about the changes in symptoms and quality of life of my patients,” said Consultant Gastroenterologist at Western General Hospital, Edinburgh and advisor to Oshi Health, Charlie Lees.

“Oshi Health is also transformative looking across patients’ data. The insights the platform can generate can help us better understand the relationship of the many factors that impact IBD including diet, environment, medication utilisation, and more. These insights are the key to moving towards predictive, hyper-personalised care,” concluded Lees.

For more information contact news@eHealthNews.co.za, like us on Facebook or tweet us @eHealthNewsZA.